etoposide has been researched along with Paraparesis, Tropical Spastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Fujii, M; Kannagi, M; Matsuoka, M; Sato, T; Yamamoto, N | 1 |
| Eguchi, K; Furuya, T; Hamasaki, S; Ichinose, K; Kawakami, A; Nakamura, T; Nakashima, T; Nishiura, Y; Shirabe, S | 1 |
2 other study(ies) available for etoposide and Paraparesis, Tropical Spastic
| Article | Year |
|---|---|
Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.
Topics: Apoptosis; Blotting, Northern; Carrier Proteins; Cell Line, Transformed; Doxorubicin; Etoposide; fas Receptor; Flow Cytometry; Gene Expression; Gene Products, tax; Human T-lymphotropic virus 1; Humans; Paraparesis, Tropical Spastic; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Protein Tyrosine Phosphatases; T-Lymphocytes | 1998 |
Resistance of CD4-positive T lymphocytes to etoposide-induced apoptosis mediated by upregulation of Bcl-xL expression in patients with HTLV-I-associated myelopathy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; CD4-Positive T-Lymphocytes; Etoposide; fas Receptor; Female; Humans; Male; Middle Aged; Paraparesis, Tropical Spastic; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2001 |